Tectonic Therapeutics TECX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $236.89M-6.7% | $253.8M-5.8% | $269.51M-6.4% | $287.97M-6.1% | $306.83M+116% | ||
| $239.89M-6.8% | $257.36M-5.8% | $273.24M-6.1% | $290.85M-6.1% | $309.64M+111% | ||
| $1.02M-13.9% | $1.19M-16.1% | $1.41M-16.1% | $1.68M-12.5% | $1.92M— | ||
| $246.58M-5.5% | $261.04M-5.8% | $277M-6.2% | $295.31M-6.2% | $314.83M+106% | ||
| $2.55M+134% | $1.09M-26.4% | $1.49M-47.0% | $2.8M-55.2% | $6.25M+541% | ||
| $265K-23.0% | $344K-16.7% | $413K-8.4% | $451K-5.1% | $475K— | ||
| $12.96M+34.1% | $9.67M+3.1% | $9.37M-17.5% | $11.36M-15.9% | $13.51M+16.4% | ||
| $16.16M+66.4% | $9.71M+2.5% | $9.47M-18.0% | $11.55M-16.3% | $13.79M+13.7% | ||
| $2K0.0% | $2K-100.0% | $150M0.0% | $150M0.0% | $150M+7,499,900% | ||
| -$247.98M-11.3% | -$222.74M-9.4% | -$203.51M-10.3% | -$184.48M-12.1% | -$164.49M-10.7% | ||
| $230.42M-8.3% | $251.33M-6.1% | $267.53M-5.7% | $283.77M-5.7% | $301.04M+114% | ||
| $246.58M-5.5% | $261.04M-5.8% | $277M-6.2% | $295.31M-6.2% | $314.83M+106% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tectonic Therapeutics's total assets?
- Tectonic Therapeutics (TECX) holds $246.6M in total assets, down 21.7% year over year.
- How much debt does Tectonic Therapeutics have?
- Tectonic Therapeutics carries $4.9M in total debt against $230.4M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Tectonic Therapeutics have?
- Tectonic Therapeutics holds $236.9M in cash and equivalents.
- Can Tectonic Therapeutics cover its short-term obligations?
- Its current ratio is 18.51 — current assets exceed current liabilities.
- Where does Tectonic Therapeutics's balance sheet data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.